| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |